MCH has invested in Farmalíder, a leading company dedicated to the research, development and manufacture of pharmaceutical specialities and products, with presence in more than 50 countries. The company is the leading supplier of ibuprofen in the Spanish market and the pioneer in the development and licensing of paracetamol in 1g tablets in the European market, with a special focus on innovation and investment in R&D.
